Worldwide Over the Counter Drugs Industry to 2025 – Competitive Analysis and the Impact of COVID-19 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Over the Counter Drugs Market (2020-2025) by Mode of Intake, Product, End-user Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.
The global over the counter drugs market is estimated to be $361 billion in 2020 and is expected to reach $539 billion by 2025, growing at a CAGR of 8.35%.
Increasing awareness regarding the personalized medicine for treating minor ailments and introduction of treatment protocols by healthcare payers and also rapidly increasing chronic diseases are some of the major driving factors making remarkable new drug development and impact positively the expansion of the over the counter (OTC) drugs market. In fact, the proper drug for the proper patient at the proper time is the mantra of personalized medicine.
Companies Mentioned
- AbbVie Inc.
- Alacer Corp.
- Alcon Inc.
- Alfresa Pharma Corporation
- Alkalon A/S
- Alkem Laboratories Limited
- Allergan, Plc.
- Alliance Healthcare
- AstraZeneca plc.
- Bausch & Lomb
- Bayer Healthcare AG
- Boehringer Ingelheim GmbH
- Cipla Ltd.
- Dr. Reddy’s Laboratories
- Gilead Sciences
- GlaxoSmithKline Plc.
- Glenmark Pharmaceuticals Ltd.
- Johnson and Johnson Inc.
- Merck & Co. Inc.
- Novartis International AG
- Pfizer Inc.
- Reckitt Benckiser Group Plc
- Roche Holding AG
- Sanofi S.A
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- The Colgate-Palmolive Company
Recent Developments
1. In July 2020, Stada AG, a Germany-based pharmaceutical company, announced about acquisition of 15 of deep-rooted OTC brands from GlaxoSmithKline in Europe. The acquisition will strengthen the company’s portfolio and presence in the consumer health business.
2. In January 2018, Nuvo Pharmaceuticals, Inc. acquired ex-U.S. product and existing royalty streams for ‘Resultz’, an OTC treatment for head lice from Piedmont Pharmaceuticals LLC.
3. Takeda Pharmaceuticals in March 2016, started overseas sales of OTC brand – Alinamin in Vietnam, India, Hong-Kong, and China.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Over the Counter Drugs Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
- The report also contains the competitive analysis using the Competitive Quadrant, the analyst’s proprietary competitive positioning tool.
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Improvement in lifestyle and age related diseases
4.2.1.2 The rise in self-directed consumer
4.2.1.3 Growing awareness regarding general health concerns and advancements in healthcare industry
4.2.2 Restraints
4.2.2.1 Stringent regulatory policies by governing bodies
4.2.2.2 Lack of seamless reclassification of drugs from prescription medicines to over the counter drugs
4.2.3 Opportunities
4.2.3.1 Increasing R&D expenditure and funding from the public & private sector
4.2.4 Challenges
4.2.4.1 Firms are seeking portfolio expansion strategies to cater to the growing demand for over-the-counter drugs.
4.3 Trends
5 Market Analysis
5.1 Porter’s Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis
6 Global Over the Counter Drugs Market, By Mode of Intake
6.1 Introduction
6.2 Topical
6.3 Oral
6.4 Parenteral
7 Global Over the Counter Drugs Market, By Product
7.1 Analgesics
7.2 Weight Loss/Dietary Products
7.3 Gastrointestinal Products
7.4 Cold, Cough and Flu Products
7.5 Mineral and Vitamin Supplements
7.6 Skin Products
7.7 Ophthalmic Products
7.8 Sleeping Aids
7.9 Dermatology Products
8 Global Over the Counter Drugs Market, By End User
8.1 Introduction
8.2 Retail Pharmacies
8.3 Online Pharmacies
8.4 Hospital Pharmacies
9 Global Over the Counter Drugs Market, By Geography
9.1 Introduction
9.2 North America
9.3 South America
9.4 Europe
9.5 Asia-Pacific
9.6 Rest of the World
10 Competitive Landscape
10.1 Competitive Quadrant
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Mergers & Acquisitions
10.3.2 Agreement, Collaborations, & Partnerships
10.3.3 New Product Launches & Enhancements
10.3.4 Investments & Funding
11 Company Profiles
12 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/mvg1cx
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
